Status:
RECRUITING
A Clinical Trial to Compare Lasotronix Alone or in Combination With CPP-ACP to Treat DH
Lead Sponsor:
Dow University of Health Sciences
Conditions:
Dentin Sensitivity
Hypersensitivity
Eligibility:
All Genders
25-65 years
Phase:
NA
Brief Summary
Dentin hypersensitivity (DH) is defined as sharp pain of a shorter duration arise from exposed dentin in response to several chemicals and thermal or tactile stimuli that cannot be ascribed to other d...
Detailed Description
DH has a prevalence rate ranging from 1.3% to 92.1%, commonly affecting old ages, and the frequency of DH in patients suffering from periodontal disease is 3-57%. Pakistan has reported prevalence from...
Eligibility Criteria
Inclusion
- Patients of either gender, with ages between 25-65 years
- should have at least more than one hypersensitive and vital tooth without any carious lesion or defective restoration
Exclusion
- History of desensitizing therapy on the affected tooth/teeth in last six months (use of desensitizing toothpaste)
- use of antibiotics /analgesic/anti-inflammatory drugs
- history of smoking
- pregnancy
- those who are not willing to participate or give follow-ups
Key Trial Info
Start Date :
May 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 10 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06463938
Start Date
May 12 2024
End Date
October 10 2024
Last Update
July 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Sanam Faheem
Karachi, Sindh, Pakistan, 75330